Patent details

EP2926817 Title: STABLE PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS

Basic Information

Publication number:
EP2926817
PCT Application Number:
MX2013000130
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP138596317
PCT Publication Number:
WO2014088385
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABLE PHARMACEUTICAL COMPOSITION FOR TREATING OSTEOPOROSIS
French Title of Invention:
COMPOSITION PHARMACEUTIQUE STABLE POUR LE TRAITEMENT DE L'OSTÉOPOROSE
German Title of Invention:
STABILE PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON OSTEOPOROSE
SPC Number:

Dates

Filing date:
30/10/2013
Grant date:
29/03/2017
EP Publication Date:
07/10/2015
PCT Publication Date:
12/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/03/2017
EP B1 Publication Date:
29/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/10/2017
Expiration date:
30/10/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/03/2017
 
 

Name:
Landsteiner Scientific S.A. de C.V.
Address:
Av. Periférico Sur n° 4118 Torre Zafiro I Piso 6 Colonia Jardines del Pedregal, 01900 Distrito Federal, Mexico (MX)

Inventor

1

Name:
REYES SANTIAGO, Alejandro
Address:
Mexico (MX)

2

Name:
GARCÍA MONDRAGÓN, María Lourdes
Address:
Mexico (MX)

Priority

Priority Number:
2012014071
Priority Date:
03/12/2012
Priority Country:
Mexico (MX)

Classification

IPC classification:
A61K 9/20; A61K 9/28; A61K 9/50; A61K 31/593; A61K 31/675; A61P 19/10;

Publication

European Patent Bulletin

Issue number:
201713
Publication date:
29/03/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
28/02/2018 Outgoing Correspondence 1